GOLDENWELL BIOTECH, INC.

GOLDENWELL BIOTECH, INC. was incorporated on August 20, 2019, and operates with a fiscal year ending December 31. The company does not have any subsidiaries. Its business offices are located at 7316 Capilano Dr., Solon, Ohio 44139, though it does not conduct operations at this location, only receiving mail. As of December 31, 2025, GOLDENWELL BIOTECH, INC. reported Cash and Cash Equivalents of $26,775, Total Assets of $26,775, Total Liabilities of $379,833, and Total Stockholders' Equity of $(343,713). The company holds two exclusive patent license agreements. Effective July 20, 2020, GOLDENWELL BIOTECH, INC. entered into an Exclusive License Agreement with Australian Trefoil Health Technologies Pty Ltd. This agreement grants the company licenses for the technology and packaging designs for its Sugar Master and DNA Repair products, as well as other products. This license covers all territories worldwide, excluding China, and is valid until November 15, 2025. The company paid $10.00 for this agreement. Australian Trefoil Health Technologies Pty Ltd is controlled by Li Yang, a director of GOLDENWELL BIOTECH, INC. Additionally, effective July 20, 2020, GOLDENWELL BIOTECH, INC. entered into an Exclusive License Agreement with Ji Lin JZY Biotech Inc. This agreement licenses the technology the company uses in its products. This license also covers all territories worldwide, excluding China, and is valid until January 11, 2035. The company paid $10.00 for this agreement. Ji Lin JZY Biotech Inc. is controlled by Shang Liu, the President, Chief Executive Officer, and a director of GOLDENWELL BIOTECH, INC.